The treatment effect correlated significantly with levels of VEGF‐A in organ culture supernatants (r = 0.94; *p < 0.05) from plaque skin and with plasma levels of VEGF‐A from patients with psoriasis (r = 0.943; *p = 0.017). This evidence concerns the gene VEGFA and psoriasis.